Evaluation of Immunoproteasome-Specific Proteolytic Activity Using Fluorogenic Peptide Substrates
- Immune Netw. 2022 Apr 15;22(3):e28. doi: 10.4110/in.2022.22.e28.
- 1. Department of Biochemistry & Molecular Biology, Seoul National University College of Medicine, Seoul 03080, Korea.
- 2. Department of Biomedical Sciences, Seoul National University Graduate School, Seoul 03080, Korea.
- 3. BK21 FOUR Biomedical Science Program, Seoul National University College of Medicine, Seoul 03080, Korea.
The 26S Proteasome irreversibly hydrolyzes polyubiquitylated substrates to maintain protein homeostasis; it also regulates immune responses by generating antigenic peptides. An alternative form of the 26S Proteasome is the immunoproteasome, which contains substituted catalytic subunits (β1i/PSMB9, β2i/PSMB10, and β5i/PSMB8) instead of constitutively expressed counterparts (β1/PSMB6, β2/PSMB7, and β5/PSMB5). The immunoproteasome expands the peptide repertoire presented on MHC class I molecules. However, how its activity changes in this context is largely elusive, possibly due to the lack of a standardized methodology to evaluate its specific activity. Here, we describe an assay protocol that measures the immunoproteasome activity of whole-cell lysates using commercially available fluorogenic peptide substrates. Our results showed that the most accurate assessment of immunoproteasome activity could be achieved by combining β5i-targeting substrate Ac-ANW-AMC and immunoproteasome inhibitor ONX-0914. This simple and reliable protocol may contribute to future studies of immunoproteasomes and their pathophysiological roles during viral Infection, inflammation, and tumorigenesis.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: ProteasomeResearch Areas: Inflammation/Immunology
-
target: ProteasomeResearch Areas: Inflammation/Immunology